1. A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study. (March 2022) Authors: Mead, Adam J.; Butt, Nauman M.; Nagi, Waseem; Whiteway, Alastair; Kirkpatrick, Suriya; Rinaldi, Ciro; Roughley, Catherine; Ackroyd, Sam; Ewing, Joanne; Neelakantan, Pratap; Garg, Mamta; Tucker, David; Murphy, John; Patel, Hitesh; Bains, Rozinder; Chiu, Gavin; Hickey, Joe; Harrison, Claire; Somerv... Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. (16th January 2015) Authors: Crow, Yanick J.; Chase, Diana S.; Lowenstein Schmidt, Johanna; Szynkiewicz, Marcin; Forte, Gabriella M.A.; Gornall, Hannah L.; Oojageer, Anthony; Anderson, Beverley; Pizzino, Amy; Helman, Guy; Abdel‐Hamid, Mohamed S.; Abdel‐Salam, Ghada M.; Ackroyd, Sam; Aeby, Alec; Agosta, Guillermo; Albin, Cath... Journal: American journal of medical genetics Issue: Volume 167:Number 2(2015:Feb.) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗